Stryker announces the acquisition of Gauss Surgical – DOTmed HealthCare Business News

KALAMAZOO, Mich., Sept. 7, 2021 /PRNewswire/ -- Stryker announced today that it has completed the acquisition of Gauss Surgical*. Headquartered in Menlo Park, CA, Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Triton has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention.

Up to 5 percent of mothers will experience a post-partum hemorrhage1, which is the leading cause of maternal death globally.2 Studies suggest that 70 percent of these are preventable.3 The Joint Commission revealed that prevention, early recognition and timely treatment of maternal hemorrhage had the highest impact on decreasing maternal complications.4

"Gauss Surgical's innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity," said Dylan Crotty, President of Stryker's Instruments division. "Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Stryker's commitment to improve safety and outcomes for our caregivers and their patients."

Ad StatisticsTimes Displayed: 448803Times Visited: 3269

About StrykerStryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Read this article:

Stryker announces the acquisition of Gauss Surgical - DOTmed HealthCare Business News